Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar, +614

The Lancet Neurology

Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade +1

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Shahram Attarian, Jean‐Michel Vallat, Laurent Magy, +29

Orphanet Journal of Rare Diseases

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features

Juliette Svahn, Philippe Petiot, Jean‐Christophe Antoine, +16

Journal of Neurology Neurosurgery & Psychiatry

Morphologic imaging in muscular dystrophies and inflammatory myopathies

Adrian Degardin, David Morillon, Arnaud Lacour, +3

Skeletal Radiology

Morphologic ImagingMedical ImagingMedicineHistopathologyDegenerative Disease +3

Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia

Tanya Stojkovic, El Hadi Hammouda, Pascale Richard, +12

Neuromuscular Disorders

DementiaValosin-containing Protein MyopathySpanish PatientsPathologyDegenerative Disease +5

Regional difference and similarity of familial amyloidosis with polyneuropathy in France

David Adams, Pierre Lozeron, Marie Théaudin, +15

Amyloid

Genetic EpidemiologyPathologyDisease Gene IdentificationClinical GeneticsAlzheimer's Disease +17

Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1

Karim Wahbi, Dominique Babuty, Vincent Probst, +18

European Heart Journal

Punctate pattern

Jérôme Hodel, Christine Darchis, Olivier Outteryck, +7

Neurology

Rituximab in refractory and non‐refractory myasthenia: A retrospective multicenter study

Nicolas Collongues, Olivier Casez, Arnaud Lacour, +4

Muscle & Nerve

JC-virus seroconversion in multiple sclerosis patients receiving natalizumab

Olivier Outteryck, Hélène Zéphir, Julia Salleron, +9

Multiple Sclerosis Journal